ARTICLE | Company News
Genzyme General, University of Michigan deal
December 4, 2000 8:00 AM UTC
GENZ obtained an exclusive license from the university to a group of small molecule glucosylceramide synthase inhibitors. The company plans to develop the compounds to treat lysosomal storage disease...